| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.5M | -15.2% | -18.8% |
| Cost of Revenue | $3.4M | -20.3% | -34.0% |
| Gross Profit | $4.1M | -10.4% | +0.0% |
| R&D Expense | $2.5M | +43.3% | +3.7% |
| SG&A Expense | $5.2M | +29.4% | +7.0% |
| Operating Income | -$6.6M | -64.9% | -3.3% |
| Net Income | -$6.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.5M | +50.8% | -1.5% |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $5.3M | +21.4% | -32.7% |
| Inventory | $10.1M | +5.6% | +12.6% |
| Current Assets | $26.7M | +21.7% | -7.5% |
| Total Assets | $45.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.7M | — | — |
| Investing Cash Flow | -$23K | — | — |
| Financing Cash Flow | $7.8M | — | — |
| -68.9% |
| -4.4% |
| EPS (Basic) | -$0.07 | -40.0% | +12.5% |
| EPS (Diluted) | -$0.07 | -40.0% | +12.5% |
| +10.7% |
| -10.5% |
| Current Liabilities | $20.4M | -1.8% | -1.7% |
| Total Liabilities | $34.1M | -1.1% | -1.9% |
| Stockholders' Equity | $6.3M | +330.4% | -42.1% |